AI-native R&D lineage
CTI's AI strategy started before the chatbot era: with structured health data, wearable signals, psychometrics, machine learning, consent, and clinical context.
Creative Thinking Institute
The AI-native parent company behind Regenemm Healthcare.
Founded in 2019, CTI builds clinically grounded AI systems for healthcare. From early work in stress-performance monitoring, body movement analysis, biosensors, sleep, and circadian health, CTI has evolved into the parent company behind Regenemm Healthcare: a hub-and-spoke clinical AI ecosystem with a secure, consent-aware, audit-grade control plane.
Built to make healthcare AI useful, explainable, and auditable
Creative Thinking Institute is the AI-native parent company behind Regenemm Healthcare. CTI began with the problem of human performance under stress, then expanded into physiology, sleep, circadian rhythm, wearable biosensors, soft sensing, rehabilitation movement analysis, and medical IoT data streams.
The GPT era accelerated the mission. CTI did not pivot from nothing into AI; it extended a pre-existing machine-learning, biosensor, and clinical-data thesis into AI-native healthcare infrastructure.
What CTI contributes
CTI is the origin, governance, research, and credibility layer. Regenemm Healthcare is the platform. Shared transparency is the product.
Secure control plane
The Regenemm Hub governs identity, consent, audit evidence, exports, persistence, cross-spoke routing, entitlements, telemetry, and compliance evidence.
AIMS provenance
AI lifecycle controls, impact assessments, system cards, data lineage, release gates, monitoring evidence, and executive risk ownership are being built into the operating model.
Hub-and-spoke maturity
Regenemm has evolved into a hub-and-spoke architecture where domain-rich clinical workflows connect to a governed platform backbone.
Responsible AI, governed from the top
AI-native governance
Regenemm Healthcare is being built with compliance and governance embedded into its operating model. CTI works with Vanta to support its formal accreditation and assurance pathway across ISO 27001, ISO 42001, HIPAA, GDPR, and SOC 2 readiness.
The operating principle is simple: no evidence means not done. Healthcare AI must be secure, auditable, explainable, and accountable from the beginning, not retrofitted after product-market fit.
That means executive oversight, AI impact assessments, lifecycle gates, system cards, data lineage, release approvals, monitoring records, incident evidence, and Vanta-linked risk ownership.
AI-native by architecture
Hub-and-spoke design, Regenemm Voice, specialist spokes, and shared transparency across care workflows.
Hub-and-spoke design, Regenemm Voice, specialist spokes, and shared transparency across care workflows.
AI-native by workflow
Voice capture, transcription, summarisation, clinical documentation, patient-facing summaries, and care-team communication.
Voice capture, transcription, summarisation, clinical documentation, patient-facing summaries, and care-team communication.
AI-native by governance
AIMS governance, executive oversight, lifecycle gates, risk and impact assessments, and release evidence.
AIMS governance, executive oversight, lifecycle gates, risk and impact assessments, and release evidence.
AI-native by evidence
Vanta-supported ISO 27001, ISO 42001, HIPAA, GDPR, SOC 2 readiness, traceability, and audit packs.
Vanta-supported ISO 27001, ISO 42001, HIPAA, GDPR, SOC 2 readiness, traceability, and audit packs.
AI-native by clinical philosophy
Clinician-in-the-loop design, patient consent, human oversight, and no autonomous clinical decision-making.
Clinician-in-the-loop design, patient consent, human oversight, and no autonomous clinical decision-making.
Flagship translation
Regenemm Healthcare is the platform expression of CTI's journey
Regenemm combines clinical AI assistants, structured documentation, patient-facing summaries, consent-aware workflows, interoperability, auditability, and compliance-led deployment.
AI is not a feature bolted onto the product. It is part of the clinical workflow architecture, data model, governance layer and operating system of the platform.
Regenemm Voice helps transform clinical conversations into structured documentation and patient-facing summaries designed to support clinician review, patient understanding, handover quality, and continuity of care.
Latest institute writing
Current thinking on AI in healthcare, clinical workflow, governance, and patient communication.
Stress-performance and preventative health origins
Body movement, rehabilitation, soft sensing, and biosensors
Sleep, circadian health, medical IoT, and data streams
Clinical documentation and patient-facing summaries
Hub-owned distribution, entitlements, and observability
Shared transparency across clinical workflows
AIMS lifecycle gates, provenance, and human oversight
Vanta-supported ISO 27001, ISO 42001, HIPAA, and GDPR pathway
AI Observability
A Different Voice - Claude's Own Reflection
🤖 Claude Sonnet 4 reflects on being interpretable AI: "Partnership, not replacement. Transparency builds trust. Humanity first."
Dr. Brendan O'Brien18 August 2025
AI Interpretable Healthcare
🚀 The Healthcare Revolution: How Multimodal AI Will Become the Invisible Infrastructure Powering Tomorrow's Medicine
🚀 Multimodal AI evolves from healthcare tool to invisible infrastructure. Real-time data fusion + edge computing = medicine's future.
Dr. Brendan O'Brien18 August 2025
AI Observability
⚖️ Navigating the Regulatory Maze: How to Deploy Safe, Compliant AI in Healthcare Without Breaking Everything
FDA approves 950+ AI devices but frameworks lag behind. New guidance creates clear compliance paths for observable healthcare AI.
Dr. Brendan O'Brien14 August 2025